期刊文献+

甲巯咪唑联合雷公藤多苷治疗甲亢患者的疗效及安全性研究 被引量:5

Efficacy and Safety of methimazole joint tripterygium glycosides treat patients with hyperthyroidism
下载PDF
导出
摘要 目的:总结探讨甲巯咪唑与雷公藤多苷联合用药治疗甲亢的临床疗效及用药安全性。方法:收治甲亢患者90例,随机分为观察组和对照组,各45例,对照组给予甲巯咪唑治疗,观察组给予甲巯咪唑联合雷公藤多苷治疗,观察比较两组患者的临床疗效、TSH变化、不良反应情况等。结果:观察组治疗总有效率97.8%明显高于对照组的86.7%(P<0.05);观察组治疗后TSH水平明显高于对照组(P<0.05)。结论:和甲巯咪唑单独用药治疗相比,与雷公藤多苷联合用药治疗甲亢疗效更佳,且用药安全。 Objective:To discuss the efficacy and safety of methimazole joint tripterygium glycosides treat patients with hyperthyroidism.Methods:90 patients with hyperthyroidism were selected,they were randomly divided into the observation group and the control group with 45 cases in each.The control group were given methimazole treatment,the observation group given methimazole combined with tripterygium glycosides treatment.The clinical efficacy,TSH changes,adverse reactions of the two groups were observed and compared.Results:The total effective rate of the observation group was 97.8%significantly higher than that in the control group of 86.7%(P<0.05),the TSH level in the observation group was significantly higher than that in the control group(P<0.05).Conclusion:Compareing with the single drug treatment with methimazole,tripterygium glycosides combined with drugs in the treatment of hyperthyroidism has better curative effect,and drug safety.
作者 张俊峰
出处 《中国社区医师》 2015年第21期67-67,69,共2页 Chinese Community Doctors
关键词 甲巯咪唑 雷公藤多苷 甲亢 临床疗效 Methimazole Tripterygium glycosides Hyperthyroidism Clinical curative effect
  • 相关文献

参考文献6

二级参考文献28

  • 1崔艳凤,王新民.抗甲状腺药物的不良反应及其相关研究进展[J].广州医药,2005,36(1):9-10. 被引量:12
  • 2朱可建,林爱华,金纳,周强,叶俊,虞海燕,程浩.雷公藤内酯醇对人树突状细胞分化成熟的抑制[J].中华微生物学和免疫学杂志,2007,27(4):330-331. 被引量:7
  • 3Fitzgeratd-Bocarsly P, Dai J, Singh S. Plasmacytoid dendritic cells and type I IFN: 50 years of convergent history. Cytokine Growth Factor Rev,2008, 19 : 3-19.
  • 4Lio YJ. IPC: professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors. Annu Rev hnmunol, 2005, 23:275-306.
  • 5Ling Y, Cao X, Yu Z,et al. Circulating dendritic cells subsets and CIM + Foxp3 + regulatory T ceils in adult patients with chron- ic ITP before and after treatment with high-dose dexamethasome. Eur J Haematol, 2007, 79:310-316.
  • 6Yang Y, Liu Z, Tolosa E, et al. Triptolide induces apoptotic death of T lymphocyte, hnmunopharmacology, 1998, 40: 139- 149.
  • 7Kadowaki N, Liu YJ. Natural type I interferon-producing cells as a link between innate and adaptive immunity. Hum lmmunol, 2002,63 : 1126-1132.
  • 8Megjugorac N J, Young HA, Amrute SB, et al. Virally stimulated plasmacytoid dendritic cells produce chemokines and induce mi- gration of T and NK ceils. J Leukoc Biol,2004,75:504-514.
  • 9Jego G, Palueka AK, Blanck JP, et al. Plasmacytoid dendritie cells induce plasma cell differentiation through type I interferon and interleukin 6. Immunity, 2003, 19:225-234.
  • 10Honda K, Yanai H, Mizutani T, et al. Role of a transductional- transcriptional processor complex involving MyD88 and IRF-7 in Toll-like receptor signalling. Proc Natl Acad Sci U S A, 2004, 101:15416-15421.

共引文献29

同被引文献31

引证文献5

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部